CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

AI-Powered SEC Filing Analysis

Insider Trading Filed: 2026-05-12

Key Insights

Director Paul Graves acquired 1,438 shares of CRL common stock on 05/08/2026 at $177.62 per share, increasing his direct beneficial ownership to 2,384 shares, demonstrating insider confidence in the company's valuation.
The acquired shares consist of unvested restricted stock units (RSUs) that vest on the earlier of May 8, 2027 or the business day prior to the next annual shareholder meeting, indicating this is equity compensation rather than open market purchase.
As a director with this acquisition, Graves maintains a modest shareholding position relative to typical institutional investor stakes, suggesting this is standard director compensation rather than a significant conviction buy or sell signal.

Insider Trading Filed: 2026-05-12

Key Insights

Director Craig B. Thompson acquired 1,438 shares of common stock at $177.62 per share on 05/08/2026, bringing his total beneficial ownership to 3,851 shares, suggesting confidence in the company's valuation at this price level.
The acquisition consists of unvested restricted stock units that vest on the earlier of 05/08/2027 or the business day prior to the next annual shareholder meeting, indicating this is a compensation-related grant rather than open market purchase.
Thompson's filing shows a relatively modest shareholding position despite his director status, with total beneficial ownership of only 3,851 shares, which may indicate limited personal capital commitment compared to institutional investors.

Insider Trading Filed: 2026-05-12

Key Insights

Director Steven Barg acquired 1,438 shares of CRL common stock at $177.62 per share on 05/08/2026, increasing his direct beneficial ownership to 2,865 shares, indicating insider confidence in the company's valuation.
The acquisition consists of unvested restricted stock units that vest on the earlier of 05/08/2027 or the business day prior to the next annual shareholder meeting, representing a typical equity compensation arrangement for board members.
This is a routine insider transaction by a director with no material trading pattern concerns; the modest share count and vesting schedule suggest standard director compensation rather than a significant strategic position change.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.